Tengjun Biotechnology Corp. (TJBH) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Tengjun Biotechnology Corp.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
32.14
Weak
WeakModerateStrong
P/B Ratio
24.96
Weak
WeakModerateStrong
Earnings Yield
3.15%
Yield Trap
WeakModerateStrong
Profitability Health
2022Return on Equity
78.50%
Strong
WeakModerateStrong
Operating Margin
10.70%
Moderate
WeakModerateStrong
Net Profit Margin
7.56%
Weak
WeakModerateStrong
Growth Indicators
2022Revenue Growth
-
No data
Net Income Growth
1616.60%
Strong
WeakModerateStrong
EPS Growth
1137.04%
Strong
WeakModerateStrong
Efficiency & Liquidity
2022Current Ratio
1.16
Moderate
WeakModerateStrong
Quick Ratio
1.14
Moderate
WeakModerateStrong
Asset Turnover
2.56x
Strong
WeakModerateStrong
Inventory Turnover
9.71x
Strong
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.37%
Weak
WeakModerateStrong
EV / Free Cash Flow
266.82x
Weak
WeakModerateStrong
Net Debt / EBITDA
-0.17x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.951
Strong
WeakModerateStrong
Return on Invested Capital
84.05%
Strong
WeakModerateStrong
Cash Conversion Cycle
-56.22 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for TJBH.
View Financial Statements